Public Backing for State-Funded Fertility Care
A new Ipsos survey commissioned by the charity Progress Educational Trust (PET) reveals broad public support across the UK, the Netherlands, Spain, and Italy for state-funded fertility treatment and embryo research. The study, which surveyed 8,688 participants, indicates that public opinion frequently exceeds current legal frameworks regarding reproductive technologies and genetic applications.
A majority of respondents in all four nations support state-funded fertility treatments for individuals experiencing infertility. According to the report, “Fertility, Embryo Research and Genome Editing: Public Attitudes in Europe,” support for such funding ranges from 54% in the Netherlands to 64% in Italy.
Embryo Research Defies National Prohibitions
Public backing for the use of human embryos in research—specifically to better understand and develop treatments for congenital diseases—remains higher than opposition in all four nations. Support levels for this research range from 41% in Italy to 48% in the Netherlands and Spain. Notably, this includes Italy, where research uses of human embryos are currently prohibited.
Public Appetite for Genome Editing
Public opinion on genome editing is highly dependent on the intended medical application. The survey found the strongest support for using genome editing to eliminate severe or life-threatening conditions in embryos intended for pregnancy. Support for this practice ranges from 46% in Italy to 55% in the Netherlands.
In the UK, the Netherlands, and Spain, a majority of respondents supported these applications, despite the fact that such applications are not currently being permitted in any of the four countries surveyed. Professor Karen Sermon, immediate past chair of the European Society of Human Reproduction and Embryology (ESHRE), noted that the findings highlight the importance of understanding public sentiment as reproductive medicine advances.
“It is particularly striking that support for some applications extends beyond what is currently permitted in certain countries,” Sermon said. “As science advances, it is essential that public awareness keeps pace, so that decisions about future treatments are informed by both evidence and societal values.”
The 14-Day Regulatory Threshold
The survey also assessed public awareness regarding the established 14-day limit for human embryo research. Among those who either supported or expressed neutrality toward embryo research, the most common sentiment was that the current 14-day limit is “about right.”
However, a significant portion of the public remains undecided on the regulatory timeline. Over one-quarter (27%) of respondents indicated they did not know whether the 14-day limit was too long, too short, or about right. Among those open to extending the limit to 28 days, the primary justification cited was finding new treatments for congenital diseases.
Generational Shifts and Surrogacy
The data suggests that attitudes toward reproductive ethics are shifting across generations. Younger respondents were consistently more likely to support sex selection than older participants. Furthermore, across all four countries, the number of respondents who believe surrogacy should be permitted exceeds the number of those who believe it should be prohibited.
Sarah Norcross, director of the Progress Educational Trust, emphasized the complexity of these findings. “There are some surprising findings, such as younger respondents in all four countries being more likely than older respondents to say that sex selection should be permitted,” Norcross stated. The study suggests that while many citizens have not yet reached a settled view on complex ethical issues, there is a clear willingness to engage with the potential medical benefits of reproductive innovation.
Keep reading